Skip to main content
Journal cover image

A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.

Publication ,  Journal Article
Pagidipati, NJ; Deedwania, P
Published in: Am J Med
September 2021

Despite decades of research into risk-reduction strategies, cardiovascular disease and renal disease remain leading causes of morbidity and mortality among patients with type 2 diabetes mellitus. Given the tight clustering of cardiovascular and renal disease with the metabolic abnormalities of type 2 diabetes mellitus, we can think of these conditions together as cardiovascular-renal-metabolic disease states. A holistic view of cardiovascular-renal-metabolic disease states is critical to provide integrated patient-centered care to individuals with these disease states. Here, we explore the cardiovascular and renal risks associated with type 2 diabetes mellitus and highlight the importance of reducing cardiovascular-renal-metabolic disease risk in a comprehensive manner. We advocate a cross-disciplinary, team-based model to manage cardiovascular-renal-metabolic disease risk among patients with type 2 diabetes mellitus.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Med

DOI

EISSN

1555-7162

Publication Date

September 2021

Volume

134

Issue

9

Start / End Page

1076 / 1084

Location

United States

Related Subject Headings

  • Risk Assessment
  • Patient-Centered Care
  • Models, Organizational
  • Humans
  • General & Internal Medicine
  • Diabetic Nephropathies
  • Diabetic Cardiomyopathies
  • Diabetic Angiopathies
  • Diabetes Mellitus, Type 2
  • Cardiometabolic Risk Factors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pagidipati, N. J., & Deedwania, P. (2021). A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus. Am J Med, 134(9), 1076–1084. https://doi.org/10.1016/j.amjmed.2021.04.024
Pagidipati, Neha J., and Prakash Deedwania. “A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.Am J Med 134, no. 9 (September 2021): 1076–84. https://doi.org/10.1016/j.amjmed.2021.04.024.
Pagidipati, Neha J., and Prakash Deedwania. “A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.Am J Med, vol. 134, no. 9, Sept. 2021, pp. 1076–84. Pubmed, doi:10.1016/j.amjmed.2021.04.024.
Journal cover image

Published In

Am J Med

DOI

EISSN

1555-7162

Publication Date

September 2021

Volume

134

Issue

9

Start / End Page

1076 / 1084

Location

United States

Related Subject Headings

  • Risk Assessment
  • Patient-Centered Care
  • Models, Organizational
  • Humans
  • General & Internal Medicine
  • Diabetic Nephropathies
  • Diabetic Cardiomyopathies
  • Diabetic Angiopathies
  • Diabetes Mellitus, Type 2
  • Cardiometabolic Risk Factors